Development of a 99mTc-Labeled Single-Domain Antibody for SPECT/CT Assessment of HER2 Expression in Breast Cancer-Reference-Cited by-同舟云学术

Development of a 99mTc-Labeled Single-Domain Antibody for SPECT/CT Assessment of HER2 Expression in Breast Cancer

Published:2021-07-30 Issue:9 Volume:18 Page:3616-3622
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zhao Lingzhou¹,Liu Changcun¹,Xing Yan¹,He Jin²,O’Doherty Jim³,Huang Wenhua⁴,Zhao Jinhua¹^ORCID

Affiliation:

1. Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100 Haining Road, Shanghai 200080, China

2. Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

3. Siemens Healthineers, Malvern, Pennsylvania 19355, United States

4. Nanomab Technology Limited, Shanghai 200080, China

Funder

Clinical Research Plan of SHDC

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.1c00569

Reference49 articles.

1. Breast Cancer Treatment

2. Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations

3. Risk Factors and Preventions of Breast Cancer

4. Clinical implications of the intrinsic molecular subtypes of breast cancer

5. Breast cancer

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

2. Preclinical research progress in HER2-targeted small-molecule probes for breast cancer;Die Radiologie;2024-07-22

3. Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [99mTc]Tc-ADAPT6;Pharmaceutics;2024-03-23

4. Preparation, Characterization, and Radiolabeling of Anti‐HER2 scFv With Technetium Tricarbonyl and Stability Studies;Journal of Labelled Compounds and Radiopharmaceuticals;2024-03-14

5. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11